Fake meat? This company is cornering the plant-based market
This could become one of the greatest growth stories of our lifetimes

This tiny plant-based firm has explosive growth
Get the FREE investor deck
Robert Lisicki, insider at Arena Pharmaceuticals
Robert Lisicki Insider Alerts

Get notified the next time Robert Lisicki buys or sells Arena Pharmaceuticals stock. Enter your email address below to get our daily insider buying and selling report.

Robert Lisicki Insider Information

Robert Lisicki has served as our Executive Vice President and Chief Commercial Officer since November 2018. Prior to joining Arena, Mr. Lisicki most recently served as General Manager, Vice President Cardio-Metabolic and Inflammation at Regeneron Pharmaceuticals, Inc. Prior to joining Regeneron, he was Senior Vice President of Sales and Marketing and Chief Customer Officer at Daiichi Sankyo, Inc. Prior to his time at Daiichi Sankyo, Mr. Lisicki held several management positions at Amgen, including Vice President and General Manager, responsible for a 700-plus-person sales force in the United States. His US leadership experiences consisted of working with such market-shaping products as Enbrel and Prolia. During his tenure, he also covered several ex-US regions and worked as an International Franchise Lead running the development and international strategies and business plans across Amgen’s portfolio, including Nephrology, Cardiology, Bone, and Oncology. Prior to joining Amgen, Mr. Lisicki held various sales and marketing positions at Johnson & Johnson. Mr. Lisicki brings over 20 years of experience in biopharmaceutical management, sales, and marketing to Arena. Mr. Lisicki holds a BS in finance and business administration from the State University of New York at Albany.

What is Robert Lisicki's net worth?

The estimated net worth of Robert Lisicki is at least $2.04 million as of August 3rd, 2021. Mr. Lisicki owns 33,601 shares of Arena Pharmaceuticals stock worth more than $2,039,245 as of October 22nd. This net worth evaluation does not reflect any other assets that Mr. Lisicki may own. Learn More.

What is Robert Lisicki's salary?

As the EVP of Arena Pharmaceuticals, Inc., Mr. Lisicki earned a total compensation package of $2,158,332.00 in 2020. Mr. Lisicki earned a salary of $428,450.00, a bonus of $10,804.00, options awards of $1,471,701.00, non-equity compensation of $229,034.00, and other compensation of $18,342.00.

How do I contact Robert Lisicki?

The corporate mailing address for Mr. Lisicki and other Arena Pharmaceuticals executives is 6154 Nancy Ridge Drive, San Diego CA, 92121. Arena Pharmaceuticals can also be reached via phone at (858) 453-7200 and via email at [email protected]

Has Robert Lisicki been buying or selling shares of Arena Pharmaceuticals?

Robert Lisicki has not been actively trading shares of Arena Pharmaceuticals during the past quarter. Most recently, Robert Lisicki sold 17,500 shares of the business's stock in a transaction on Tuesday, August 3rd. The shares were sold at an average price of $60.08, for a transaction totalling $1,051,400.00. Following the completion of the sale, the executive vice president now directly owns 33,601 shares of the company's stock, valued at $2,018,748.08.

Who are Arena Pharmaceuticals' active insiders?

Arena Pharmaceuticals' insider roster includes Jayson Dallas (Director), Robert Lisicki (EVP), Robert Lisicki (EVP), and Amit Munshi (CEO).

Are insiders buying or selling shares of Arena Pharmaceuticals?

During the last year, Arena Pharmaceuticals insiders bought shares 4 times. They purchased a total of 3,005 shares worth mmore than $151,841.25. During the last year, insiders at the biopharmaceutical company sold shares 9 times. They sold a total of 161,468 shares worth mmore than $12,426,897.02. The most recent insider tranaction occured on August, 16th when Amit Munshi CEO bought 1,000 shares worth more than $48,190.00. Insiders at Arena Pharmaceuticals own 2.4 % of the company.

Information on this page was last updated on 8/16/2021.

Robert Lisicki Insider Trading History at Arena Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/3/2021Sell17,500$60.08$1,051,400.0033,601View SEC Filing Icon  
2/2/2021Sell17,500$78.87$1,380,225.0026,941View SEC Filing Icon  
8/4/2020Sell30,000$63.34$1,900,200.0030,000View SEC Filing Icon  
11/13/2019Sell4,429$45.83$202,981.07View SEC Filing Icon  
See Full Table

Robert Lisicki Buying and Selling Activity at Arena Pharmaceuticals

This chart shows Robert Lisicki's buying and selling at Arena Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arena Pharmaceuticals Company Overview

Arena Pharmaceuticals logo
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.
Read More

Today's Range

Now: $60.69
Low: $60.34
High: $61.42

50 Day Range

MA: $56.84
Low: $45.80
High: $63.74

2 Week Range

Now: $60.69
Low: $45.50
High: $90.19


8,098 shs

Average Volume

477,477 shs

Market Capitalization

$3.71 billion

P/E Ratio


Dividend Yield



Can this company fix a broken $4T+ healthcare industry?
43.4% of adults and 82M Americans lack adequate healthcare.

This firm's found a niche and could transform a $4T+ healthcare space.
See who this innovator is ASAP.